tetrahydrocannabivarin 9 has been researched along with Innate Inflammatory Response in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bolognini, D; Cascio, MG; Comelli, F; Costa, B; Di Marzo, V; Gauson, LA; Maione, S; Marini, P; Parolaro, D; Pertwee, RG; Ross, RA | 1 |
1 other study(ies) available for tetrahydrocannabivarin 9 and Innate Inflammatory Response
Article | Year |
---|---|
The plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice.
Topics: Animals; Cell Line, Transformed; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Dose-Response Relationship, Drug; Dronabinol; Edema; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Inflammation; Male; Membranes; Mice; Mice, Inbred C57BL; Pain; Pain Measurement; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Spleen | 2010 |